Tagomics Secures £860k Innovate UK Grant for Cancer Detection
Deal News | Jun 10, 2025 | Business Cloud
A Cambridge-based MedTech startup, Tagomics, has been awarded £860,000 from Innovate UK as part of the Biomedical Catalyst programme. This funding is aimed at advancing the company's Interlace platform, which focuses on the early detection of colorectal cancer through disease-associated DNA biomarker discovery. The project, totaling £1.2 million, also includes Tagomics' own financial contribution. The study, led by Dr. Arash Assadsangabi in collaboration with Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection, aims to profile 250 patients and validate biomarker efficacy. Tagomics co-founder Dr. Robert Neely expressed optimism about improving patient outcomes with the Interlace technology. Agilent Technologies will continue collaboration to enhance the platform's capabilities, reinforcing the prospects for its application in cancer research.
Sectors
- MedTech
- Biotechnology
Geography
- United Kingdom – The article focuses on Innovate UK's funding of a UK-based startup, Tagomics, and includes collaborations with UK health institutions.
Industry
- MedTech – This article is centered around medical technology, specifically in regards to innovative diagnostic and therapeutic solutions for cancer detection.
- Biotechnology – The use of biotechnology is evident in Tagomics' work on biomarker discovery and diagnostic platforms for colorectal cancer.
Financials
- £860,000 – Grant provided by Innovate UK to Tagomics for their colorectal cancer detection project.
- £1.2 million – Total project cost for customizing Tagomics' platform, with Tagomics contributing the remaining funds.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Tagomics | Target Company | Company | A Cambridge-based biomarker discovery and diagnostics startup focused on innovative healthcare solutions. |
| Innovate UK | Funding Agency | Government | The UK's innovation agency providing funding for projects with potential impacts on UK healthcare solutions. |
| Salford Royal NHS Foundation Trust | Collaborator | Government | An NHS foundation involved in the pilot study for colorectal cancer detection. |
| Northern Care Alliance Research Collection | Collaborator | Government | A biobank collaborating on the colorectal cancer detection study. |
| Dr. Arash Assadsangabi | Lead Researcher | Person | Consultant physician and gastroenterologist leading the study. |
| Dr. Robert Neely | CSO & Co-founder | Person | Chief Scientific Officer and co-founder of Tagomics. |
| Agilent Technologies | Collaborator | Company | A technology company supporting the development and application of Tagomics' platform. |
| Dr. Rita Shaknovich | Chief Medical Officer | Person | Chief Medical Officer at Agilent Technologies, praising Tagomics' achievements. |